官方服务：
资源简介：
Compounds profiling on MCF7
应用场景：
创建时间：
2010-07-14
相关数据集
In vitro evaluation of the anti-breast cancer properties and gene expression profiles of Thai traditional formulary medicine extracts
Breast cancer (BC) is a major public health problem leading cause of cancer death both in Thailand and worldwide. In 2020, BC is the third most common type of cancer in Thailand. The occurrence rate o
NIAID Data Ecosystem60
Complete analysis of data from screening for antitubercular activity and physico chemical properties of the hit compounds.
Rifampicin and Isoniazid were taken as controls. MIC values for controls against M. smegmatis are Rif-2.43±0.02μM and Inh-11.03±0.05 μM and H37Rv are Rif-0.08±0.01μM and Inh-0.22±0.3 μM.
NIAID Data Ecosystem60
Score combining binding energy and permeability.
* ΔGb are energy values in kcal/mol using the MM/GBSA method (Table 3). † S+Peff is the human jejunal effective permeability expressed in 104 cm/s. ‡ The score is calculated based on a function combin
NIAID Data Ecosystem50
BET–HDAC Dual Inhibitors for Combinational Treatment of Breast Cancer and Concurrent Candidiasis
Breast cancer is susceptible to Candida infections, and candidiasis has an enhancing effect on the progression and metastasis of tumor. Breast cancer and concurrent candidiasis represent a significant
NIAID Data Ecosystem60
GDC-9545 (Giredestrant): A Potent and Orally Bioavailable Selective Estrogen Receptor Antagonist and Degrader with an Exceptional Preclinical Profile for ER+ Breast Cancer
Breast cancer remains a leading cause of cancer death in women, representing a significant unmet medical need. Here, we disclose our discovery efforts culminating in a clinical candidate, 35 (GDC-9545
NIAID Data Ecosystem50
